Article Details

-$0.61 EPS Expected for Moleculin Biotech, Inc. (NASDAQ:MBRX) This Quarter

Retrieved on: 2021-02-23 13:41:15

Tags for this article:

Click the tags to see associated articles and topics

-$0.61 EPS Expected for Moleculin Biotech, Inc. (NASDAQ:MBRX) This Quarter. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 948,503 shares of the company's stock worth $756,000 after purchasing an additional 57,362 shares in the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up